Cargando…
Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
Whilst literature is expanding on pasireotide use in the management of Cushing’s disease (CD), there is still currently much unknown about long-term and low-dose pasireotide use in CD. We present a 60-year-old female with residual CD after transphenoidal surgery (TSS), being successfully managed wit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923187/ https://www.ncbi.nlm.nih.gov/pubmed/33865235 http://dx.doi.org/10.1530/EDM-20-0206 |